Squarepoint Ops LLC Nkarta, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 62,214 shares of NKTX stock, worth $146,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,214

Previous 179,194 65.28%

Holding current value

$146,202

Previous $1.06 Million 73.47%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.52 - $8.0 $528,749 - $935,840	-116,980 Reduced 65.28%	62,214 $281,000
Q2 2024 Aug 14, 2024	BUY	$5.27 - $10.82 $432,129 - $887,218	81,998 Added 84.36%	179,194 $1.06 Million
Q1 2024 May 15, 2024	BUY	$5.59 - $15.71 $338,496 - $951,303	60,554 Added 165.26%	97,196 $1.05 Million
Q4 2023 Feb 14, 2024	BUY	$1.31 - $6.6 $14,700 - $74,065	11,222 Added 44.15%	36,642 $241,000
Q2 2023 Aug 14, 2023	SELL	$2.19 - $5.17 $178,463 - $421,303	-81,490 Reduced 76.22%	25,420 $55,000
Q1 2023 May 15, 2023	SELL	$3.37 - $6.3 $526,707 - $984,645	-156,293 Reduced 59.38%	106,910 $379,000
Q4 2022 Feb 14, 2023	BUY	$5.14 - $14.35 $1.26 Million - $3.51 Million	244,921 Added 1339.68%	263,203 $1.58 Million
Q3 2022 Nov 14, 2022	SELL	$12.27 - $18.39 $242,798 - $363,901	-19,788 Reduced 51.98%	18,282 $241,000
Q2 2022 Aug 15, 2022	BUY	$7.77 - $19.44 $295,803 - $740,080	38,070 New	38,070 $469,000
Q2 2021 Aug 16, 2021	SELL	$23.94 - $36.68 $276,626 - $423,837	-11,555 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$31.33 - $59.61 $214,077 - $407,315	6,833 Added 144.71%	11,555 $380,000
Q4 2020 Feb 16, 2021	SELL	$27.03 - $75.62 $144,961 - $405,550	-5,363 Reduced 53.18%	4,722 $290,000
Q3 2020 Nov 16, 2020	BUY	$23.52 - $47.9 $237,199 - $483,071	10,085 New	10,085 $303,000

Others Institutions Holding NKTX

# of Institutions

129

Shares Held

66.5M

Call Options Held

173K

Put Options Held

20K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $114M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Nkarta, Inc. Transaction History